CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Tibet Rhodiola Pharmaceutical Holding Company Company Snapshot
Tibet Rhodiola Pharmaceutical Holding Company operates in the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tibet Rhodiola Pharmaceutical Holding Company with three other companies in this sector in China: GuangYuYuan Chinese Herbal Medicine Co Ltd (2017 sales of 1.17 billion Chinese Renmimbi [US$167.85 million] ), China NT Pharma Group Co Ltd (604.85 million Chinese Renmimbi [US$86.95 million] ), and Kingworld Medicines Group Limited (1.03 billion Chinese Renmimbi [US$148.29 million] ).

Sales Analysis. Tibet Rhodiola Pharmaceutical Holding Company reported sales of 915.63 million Chinese Renmimbi (US$131.63 million) for the year ending December of 2017. This represents an increase of 14.9% versus 2016, when the company's sales were 796.77 million Chinese Renmimbi. Despite this increase, sales are still well below the level achieved in 2015, when Tibet Rhodiola Pharmaceutical Holding Company reported sales of 1.38 billion Chinese Renmimbi. Sales of Other saw an increase that was more than double the company's growth rate: sales were up 211.9% in 2017, from 2.19 million Chinese Renmimbi to 6.83 million Chinese Renmimbi. Not all segments of Tibet Rhodiola Pharmaceutical Holding Company experienced an increase in sales in 2017: sales of Pharmaceutical Manufacturing Industry fell 60.3% to 315.35 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Tibet Rhodiola Pharmaceutical Holding Company
  Stock Performance Chart for Tibet Rhodiola Pharmaceutical Holding Company
 
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 31.45
(Figures in Chinese Renmimbi)
1 Week -0.4%   13 Weeks 14.2%  
4 Weeks -3.6%   52 Weeks -20.3%  
 
Tibet Rhodiola Pharmaceutical Holding Company Key Data:
  Ticker: 600211 Country: China
  Exchanges: SHG Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2017 Sales 915,625,718
(Year Ending Jan 2018).
Employees: 465
  Currency: Chinese Renmimbi Market Cap: 5,649,023,997
  Fiscal Yr Ends: December Shares Outstanding: 179,619,205
  Share Type: A Gu Closely Held Shares: 115,381,437
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.